Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCVA
2626
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
| $9.84M | ﹤0.01% |
1,009,204
-13,736
| -1% | -$134K |
|
|
FVT
2627
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $9.84M | ﹤0.01% |
1,000,649
-406
| -0% | -$3.99K |
|
2628
CALL
Huntsman Corp
HUN
$1.81B
| $9.79M | ﹤0.01% |
345,400
-28,100
| -8% | -$949K |
|
2629
Keros Therapeutics
KROS
$200M
| $9.79M | ﹤0.01% |
354,354
+74,193
| +26% | +$3.26M |
|
|
BAND
2630
Bandwidth Inc
BAND
$1.74B
| $9.79M | ﹤0.01% |
520,060
+68,351
| +15% | +$1.58M |
|
2631
Hayward Holdings
HAYW
$3.22B
| $9.79M | ﹤0.01% |
680,052
+224,311
| +49% | +$3.46M |
|
2632
CALL
VeriSign
VRSN
$25.7B
| $9.77M | ﹤0.01% |
58,400
+31,200
| +115% | +$5.72M |
|
|
LGV
2633
DELISTED
Longview Acquisition Corp. II
LGV
| $9.76M | ﹤0.01% |
999,431
+46,964
| +5% | +$459K |
|
2634
CALL
Knight Transportation
KNX
$11.8B
| $9.76M | ﹤0.01% |
210,800
+126,400
| +150% | +$5.98M |
|
2635
CALL
Penske Automotive Group
PAG
$14.4B
| $9.76M | ﹤0.01% |
93,200
+56,600
| +155% | +$6.07M |
|
2636
Vanguard Total International Bond ETF
BNDX
$82.7B
| $9.76M | ﹤0.01% |
+196,922
| New | +$9.94M |
|
|
MDRX
2637
DELISTED
Veradigm Inc. Common Stock
MDRX
| $9.75M | ﹤0.01% |
657,518
-1,238,943
| -65% | -$23.2M |
|
|
CLR
2638
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $9.75M | ﹤0.01% |
149,200
-69,800
| -32% | -$4.42M |
|
2639
C3.ai
AI
$1.54B
| $9.73M | ﹤0.01% |
532,659
+503,665
| +1,737% | +$9.26M |
|
2640
PUT
Alpha Metallurgical Resources
AMR
$2.11B
| $9.72M | ﹤0.01% |
75,300
-14,800
| -16% | -$2.24M |
|
2641
CALL
QuidelOrtho
QDEL
$981M
| $9.7M | ﹤0.01% |
99,780
-40,520
| -29% | -$4.13M |
|
2642
Jacobs Solutions
J
$16.9B
| $9.69M | ﹤0.01% |
92,114
-220,743
| -71% | -$24.7M |
|
2643
Vanguard Morningstar Value ETF
VTV
$194B
| $9.68M | ﹤0.01% |
73,408
+54,666
| +292% | +$7.71M |
|
|
SDST
2644
Stardust Power Inc
SDST
$9.45M
| $9.68M | ﹤0.01% |
98,161
-29,895
| -23% | -$2.94M |
|
2645
Danaos Corp
DAC
$2.58B
| $9.67M | ﹤0.01% |
153,195
+82,519
| +117% | +$6.61M |
|
2646
CALL
Lantheus
LNTH
$6.59B
| $9.67M | ﹤0.01% |
146,400
+24,500
| +20% | +$1.54M |
|
2647
Cogent Biosciences
COGT
$6.58B
| $9.66M | ﹤0.01% |
1,071,514
+1,006,013
| +1,536% | +$6.87M |
|
|
FSR
2648
DELISTED
Fisker Inc.
FSR
| $9.66M | ﹤0.01% |
1,127,735
-112,531
| -9% | -$1.17M |
|
2649
CALL
Mid-America Apartment Communities
MAA
$15.5B
| $9.66M | ﹤0.01% |
55,300
+4,000
| +8% | +$744K |
|
2650
CALL
Fulgent Genetics
FLGT
$511M
| $9.66M | ﹤0.01% |
177,100
+11,600
| +7% | +$638K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.